Clinical Trials Logo

Clinical Trial Summary

Automatic and non-invasive diagnostic methods based on the analysis of internal (intraluminal) and external (abdominal) images have been recently developed to measure intestinal motility. In patients with severe motor disorders, such as intestinal pseudo-obstruction, these new non-invasive techniques have shown to be equivalent to conventional intestinal manometry, the current gold-standard. However, these new techniques also detect less obvious signs of intestinal motor dysfunction, which are not detectable by conventional manometry. High resolution manometry has been recently been applied to other parts of the digestive tract with great success, and probably will replace the actual gold-standard for intestinal motility evaluation. The investigators expect high-resolution manometry to be more sensitive than conventional manometry to the subtle motility disturbances detected by the new non-invasive techniques. The purpose of this project is to demonstrate that intestinal motor function can be measured more sensitively and accurately using a combination of new technologies: high resolution manometry and the non-invasive diagnostic methods based on the analysis of images. The combined use of these techniques, following a step-wise algorithm, could allow to determine the mechanism, the affected regions and severity of the dysfunction in patients with intestinal dysmotility.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Gastrointestinal Motility Disorder

NCT number NCT04764019
Study type Interventional
Source Hospital Universitari Vall d'Hebron Research Institute
Contact Carolina Malagelada, MD
Phone 34 932746259
Email cmalagelada@vhebron.net
Status Recruiting
Phase N/A
Start date November 7, 2018
Completion date February 28, 2022

See also
  Status Clinical Trial Phase
Completed NCT04429802 - The Effect of Prucalopride (Resolor®) on Gastric Motor Function and Gastric Sensitivity N/A
Completed NCT01644240 - A Phase 1, Multiple Intravenous Dose Study to Examine the Safety, Tolerability, and Pharmacokinetics of Intravenous TD-8954, a 5-HT4 Receptor Agonist, in Healthy Subjects Phase 1
Withdrawn NCT04244877 - Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility Phase 3
Terminated NCT02573519 - Gastrointestinal Motility Among Diabetes Patients N/A
Completed NCT03012594 - Lanreotide in the Treatment of Small Bowel Motility Disorders Phase 2
Not yet recruiting NCT05268328 - The Effect of Foot Reflexology After Cesarean Section
Completed NCT02245165 - Nitric Oxide Control of Migrating Motor Complex: L-NMMA Effects in Relation to Receptor Blockades Phase 1
Completed NCT03552510 - Oropharyngeal Administration of Mother's Milk in Preterm Infants and Gastrointestinal Motility N/A
Completed NCT01394055 - Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis Phase 1
Active, not recruiting NCT00793195 - Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants? Phase 2
Recruiting NCT04208828 - IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy
Active, not recruiting NCT06347367 - Short-term Effect of Exercise and Self-manual Approaches to Bloating - Distention N/A
Recruiting NCT05989763 - Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis N/A
Recruiting NCT04988438 - Gastrointestinal Motor Disorders (Esophageal and Anorectal) After COVID-19
Completed NCT01635608 - Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric Water Phase 1